Geode Capital Management
CCRN

Geode Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Geode Capital Management’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.42M Sell
789,471
-104,149
-12% -$933K ﹤0.01% 2544
2025
Q4 		$7.24M Buy
893,620
+14,733
+2% +$161K ﹤0.01% 2567
2025
Q3 		$12.5M Buy
878,887
+50,144
+6% +$662K ﹤0.01% 2282
2025
Q2 		$10.8M Buy
828,743
+10,332
+1% +$142K ﹤0.01% 2314
2025
Q1 		$12.2M Buy
818,411
+64,043
+8% +$1.1M ﹤0.01% 2168
2024
Q4 		$13.7M Buy
754,368
+2,112
+0.3% +$28.4K ﹤0.01% 2163
2024
Q3 		$10.1M Sell
752,256
-35,752
-5% -$527K ﹤0.01% 2367
2024
Q2 		$10.9M Buy
788,008
+19,656
+3% +$311K ﹤0.01% 2270
2024
Q1 		$14.4M Buy
768,352
+14,349
+2% +$287K ﹤0.01% 2108
2023
Q4 		$17.1M Buy
754,003
+29,752
+4% +$645K ﹤0.01% 2010
2023
Q3 		$18M Buy
724,251
+23,289
+3% +$586K ﹤0.01% 1889
2023
Q2 		$19.7M Sell
700,962
-4,889
-0.7% -$121K ﹤0.01% 1866
2023
Q1 		$15.8M Buy
705,851
+24,857
+4% +$651K ﹤0.01% 1958
2022
Q4 		$18.1M Buy
680,994
+10,991
+2% +$359K ﹤0.01% 1837
2022
Q3 		$19M Buy
670,003
+18,041
+3% +$464K ﹤0.01% 1769
2022
Q2 		$13.6M Buy
651,962
+11,819
+2% +$221K ﹤0.01% 2037
2022
Q1 		$13.9M Buy
640,143
+24,997
+4% +$542K ﹤0.01% 2130
2021
Q4 		$17.1M Buy
615,146
+5,062
+0.8% +$123K ﹤0.01% 2063
2021
Q3 		$13M Sell
610,084
-84
-0% -$1.58K ﹤0.01% 2271
2021
Q2 		$10.1M Buy
610,168
+20,148
+3% +$308K ﹤0.01% 2452
2021
Q1 		$7.37M Buy
590,020
+62,878
+12% +$667K ﹤0.01% 2568
2020
Q4 		$4.67M Sell
527,142
-13,739
-3% -$112K ﹤0.01% 2640
2020
Q3 		$3.51M Buy
540,881
+12,270
+2% +$77.8K ﹤0.01% 2587
2020
Q2 		$3.25M Buy
528,611
+10,026
+2% +$61.5K ﹤0.01% 2560
2020
Q1 		$3.5M Buy
518,585
+32,676
+7% +$310K ﹤0.01% 2356
2019
Q4 		$5.65M Buy
485,909
+7,526
+2% +$85K ﹤0.01% 2379
2019
Q3 		$4.93M Buy
478,383
+24,837
+5% +$244K ﹤0.01% 2391
2019
Q2 		$4.25M Buy
453,546
+29,886
+7% +$230K ﹤0.01% 2501
2019
Q1 		$2.98M Buy
423,660
+39,865
+10% +$342K ﹤0.01% 2614
2018
Q4 		$2.81M Buy
383,795
+23,444
+7% +$197K ﹤0.01% 2566
2018
Q3 		$3.15M Buy
360,351
+19,063
+6% +$195K ﹤0.01% 2649
2018
Q2 		$3.84M Buy
341,288
+26,519
+8% +$316K ﹤0.01% 2483
2018
Q1 		$3.5M Buy
314,769
+9,845
+3% +$123K ﹤0.01% 2465
2017
Q4 		$3.89M Buy
304,924
+7,991
+3% +$106K ﹤0.01% 2353
2017
Q3 		$4.22M Buy
296,933
+9,282
+3% +$116K ﹤0.01% 2304
2017
Q2 		$3.71M Buy
287,651
+18,656
+7% +$240K ﹤0.01% 2351
2017
Q1 		$3.86M Buy
268,995
+10,582
+4% +$156K ﹤0.01% 2264
2016
Q4 		$4.03M Buy
258,413
+34,668
+15% +$475K ﹤0.01% 2197
2016
Q3 		$2.63M Buy
223,745
+5,194
+2% +$68.4K ﹤0.01% 2390
2016
Q2 		$3.04M Buy
218,551
+662
+0.3% +$8.77K ﹤0.01% 2210
2016
Q1 		$2.53K Buy
217,889
+14,219
+7% +$181K ﹤0.01% 2294
2015
Q4 		$3.34M Buy
203,670
+2,275
+1% +$36.2K ﹤0.01% 2148
2015
Q3 		$2.74M Buy
201,395
+12,252
+6% +$166K ﹤0.01% 2226
2015
Q2 		$2.4M Sell
189,143
-3,350
-2% -$38K ﹤0.01% 2381
2015
Q1 		$2.28M Buy
192,493
+10,425
+6% +$119K ﹤0.01% 2356
2014
Q4 		$2.27M Buy
182,068
+7,717
+4% +$78.8K ﹤0.01% 2346
2014
Q3 		$1.62M Buy
174,351
+14,248
+9% +$109K ﹤0.01% 2485
2014
Q2 		$1.04M Sell
160,103
-28,100
-15% -$186K ﹤0.01% 2775
2014
Q1 		$1.52M Buy
188,203
+4,470
+2% +$44K ﹤0.01% 2513
2013
Q4 		$1.83M Buy
183,733
+48,388
+36% +$336K ﹤0.01% 2348
2013
Q3 		$820K Buy
135,345
+4,711
+4% +$27K ﹤0.01% 2702
2013
Q2 		$674K Buy
+130,634
New +$669K ﹤0.01% 2700

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Geode Capital Management's CCRN Position: Q1 2026 in Review

Geode Capital Management reduced its Cross Country Healthcare (CCRN) stake by 12% in Q1 2026, selling an estimated $933K and leaving 789,471 shares worth $7.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2544.

Geode Capital Management first reported a position in CCRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.7M in Q2 2023. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Geode Capital Management held 789,471 shares of Cross Country Healthcare worth $7.42M as of Q1 2026.
  • Geode Capital Management sold 104,149 Cross Country Healthcare shares in Q1 2026, an estimated $933K.
  • Cross Country Healthcare made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2544 holding.
  • Geode Capital Management first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Geode Capital Management's Cross Country Healthcare position peaked at $19.7M in Q2 2023.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.